Reorganised: October 24, 2026. Assessment: Not assessed.
This is a simulated portfolio exercise, not an NHS implementation or official approval checklist. Priorities, owner roles, dependencies and completion criteria below are proposals derived from this page, not agreed assignments or governance decisions. All assignees remain To assign; no due dates are committed.
Priority: P0 = establish scope and safety/data controls; P1 = prepare and test the simulation; P2 = consider a simulated pilot, monitoring and evaluation. Rows are in recommended order. Drafting can run in parallel where dependencies are marked “inputs”; final review depends on those inputs being resolved.
Evidence boundary: The existing scenario, checklist, illustrative hazards, measure definitions and blank records are planning material. They do not establish safety, approval, UAT success or benefits. New scope/workflow drafts and a constructed document walkthrough are now linked below. These are AI-assisted portfolio artifacts awaiting Jeongmi’s review; no external evidence, product UAT, clinical approval or deployment results have been collected.
Each evidence ID links by identifier to the separate “Evidence needed” register below. Completion criteria refer to portfolio deliverables only; real supplier documentation, governance reviews and approvals cannot be replaced by synthetic evidence.
| ID / priority | Action / source section | Proposed owner role — To assign | Dependencies | Portfolio completion criteria | Next single step | Evidence ID | Status |
|---|---|---|---|---|---|---|---|
| A01 · P0 | Define intended use and workflow (§1) | Clinical informatics lead + service clinical lead | None | Scope names patient group, setting, users, purpose and exclusions; map covers consultation → draft → review → EPR → correction. | Review scope/workflow v0.2 and decision log in page 01; record accept/revise outcomes for D01–D04 and comments on D05–D06. User review pending; external evidence X01–X08 remains evidence needed. | E01 | In progress — draft artifact; review pending |
| A02 · P0 | Identify product/version and governance questions (§1–2) | Digital governance lead + clinical safety role | A01 | Product/version and supplier claims are traceable, or explicitly unresolved; required reviews and responsible roles are listed. No regulatory status inferred. | Create a supplier-question list covering product version, intended use and status documentation. | E02 | Open |
| A03 · P0 | Map IG and data flows (§3) | IG/data protection lead + technical lead | A01; A02 inputs | Map covers audio, transcript, draft and EPR note; access, hosting, transfers, retention/deletion and supplier reuse are documented or marked unknown; review gaps remain explicit. | Draw the data lifecycle with question marks for every unconfirmed system, recipient and retention period. | E03 | Open |
| A04 · P0 | Develop clinical safety and downtime assessment (§2,4,7) | Clinical safety role + service clinical lead | A01; A02–A03 inputs | Hazards have impacts, proposed controls, accountable roles, test links and residual-risk questions; escalation, stop-use and manual fallback steps are defined. Untested controls remain unverified. | Extend the existing illustrative hazard log with omitted allergies, outage, control-test and residual-risk columns. | E04 | In progress — draft artifact; review pending |
| A05 · P0 | Define human review, identity and audit controls (§3–4) | Reviewing clinician role + EPR lead | A01; A03–A04 inputs | SOP covers patient/encounter checks; missing/conflicting data; medicines, allergies, diagnoses, follow-up and safety-netting; authorisation, corrections and edit/version audit; testable stop-use rules. | Review checklist v0.1, then add the missing full responsibility matrix and EPR audit requirements. | E05 | In progress — draft artifact; review pending |
| A06 · P1 | Prepare patient information and accessible alternative (§6,9) | Patient experience/accessibility lead + IG lead | A01; A03; A05 | Draft explains recordings, data access, supplier role and limitations; governance questions on consent/other requirements are unresolved until supported; decline/manual pathway, language needs and adjustments are specified. | Draft a patient information outline and list unanswered data-use and accessibility questions. | E06 | Open |
| A07 · P1 | Design baseline, feedback and benefit evaluation (§8–9; Pilot measures) | Evaluation analyst + clinical informatics lead | A01; A04–A06 inputs | Protocol defines measures, denominators, periods, sample rationale, subgroup limits and proposed threshold-setting roles; total review/correction time, costs, errors and contextual changes are covered. No results claimed. | Create a measurement dictionary for the existing pilot measures and a blank feedback log for patients, clinicians and administrative users. | E07 | Open |
| A08 · P1 | Design and execute synthetic UAT (§3,5–6) | UAT lead + clinical/EPR reviewers | A01–A06; A07 measures | Cases cover typical/complex consultations, accents, noise, interruptions, terminology, missing/conflicting information, wrong encounter and omitted follow-up; each executed case has expected/actual result, version, issue and retest evidence. Unexecuted cases stay open. | Repeat SYN-01 independently and record observations; then design the separate wrong-encounter case without inventing product results. | E08 | In progress — draft artifact; review pending |
| A09 · P1 | Prepare role-specific training and competency checks (§5) | EPR training lead + clinical educator | A05; A08 findings | Materials cover limitations, safe review, corrections, fallback and reporting; competency scenarios and required reviewer roles are recorded; attendance and competence are not assumed. | Draft a short training outline and one competency scenario about an incorrect medication dose. | E09 | Open |
| A10 · P1 | Define incident, support and continuity arrangements (§7,9) | Service operations lead + clinical safety + technical lead | A02–A05; A08 findings | Procedure covers incidents/near misses, urgent escalation, support roles, supplier/regulator reporting decision points and unresolved local routes; synthetic export/handover and supplier-exit checks are defined. | Create a role-based escalation map with local contacts/reporting requirements labelled evidence needed. | E10 | Open |
| A11 · P2 | Prepare limited simulated pilot and decision gate (§7) | Service clinical lead + project lead | A01–A10 evidence review | Plan defines scope, duration, proposed accountable roles, entry/exit criteria, support, rollback and review schedule; unresolved evidence blocks an affirmative readiness decision; no NHS sign-off is implied. | Draft a pilot entry checklist referencing E01–E10; leave threshold values and approval fields unconfirmed. | E11 | Open |
| A12 · P2 | Set up monitoring and change control (§8) | Clinical informatics lead + safety/evaluation roles | A07; A10–A11 | Dashboard specification tracks time, errors, corrections, review compliance, equity, safety and feedback; review cadence and escalation rules are proposed; version/workflow changes trigger documented risk, UAT and training reassessment. | Create a blank monitoring template and change log with a reassessment-trigger column. | E12 | Open |
| A13 · P2 | Complete balanced portfolio evaluation (§9) | Evaluation lead + portfolio author | A07; A11–A12; actual simulation outputs | Linked synthetic baseline/follow-up records include definitions, sample counts and context; report includes burdens, errors, feedback, costs and limitations; no causation or real deployment benefit claimed without evidence. | Draft the evaluation report headings, keeping all results as not measured/not collected. | E13 | Open |
External/approval evidence remains evidence needed for E01–E13. Draft portfolio artifacts are linked below for E01, E04, E05 and E08; they do not satisfy all completion criteria. The “existing material” column records only what is visible on this page, not proof that a check has passed.
| Evidence ID | Existing material and limits | Evidence needed |
|---|---|---|
| E01 | Scope/workflow v0.2 review copy and decision log prepared on 25 October 2026 in page 01. C01–C03 separate documented portfolio boundaries from D01–D06 unconfirmed decisions and X01–X08 external evidence gaps. Awaiting Jeongmi’s review; no approved service assumptions. | Intended-use statement, workflow map and decision log drafted in page 01; documented user review/outcomes and applicable external service evidence remain needed. Drafting does not close E01. |
| E02 | No identified product/version or reviewed supplier evidence. | Versioned supplier documentation; status/claims source; governance-review requirements and questions. |
| E03 | Questions listed only; no confirmed data-flow or IG review. | Data-flow map; access matrix; retention/deletion and supplier-use evidence; IG/data protection review record or explicit external-review gap. |
| E04 | Four illustrative hazards and proposed controls exist; not tested. | Expanded hazard log; control-test links; safety-review record; downtime, stop-use and escalation procedure. Real clinical review remains external evidence needed. |
| E05 | Review checklist v0.1 and a synthetic correction/change record drafted. No full SOP, EPR audit trail or clinical authorisation. | Review SOP; responsibility matrix; synthetic patient/encounter, correction and authorisation test records; sample audit trail. |
| E06 | Requirements listed; no patient material or accessibility assessment. | Patient information draft; alternative pathway; accessibility assessment; governance determination of applicable requirements; comprehension-test evidence if performed. |
| E07 | Measure ideas, blank baseline table and hypothetical feedback prompts exist; no observations. | Measurement dictionary; baseline/evaluation protocol; feedback collection plan; contextual change log; justified proposed thresholds and decision roles. |
| E08 | SYN-01 contains a constructed source, deliberately incomplete draft, corrected note and assistant text comparison. No product UAT executed. | Versioned synthetic cases; expected/actual results; defect/retest log; review/sign-off requirements. Test plan alone is not a pass. |
| E09 | No training plan or competency evidence. | Role-based training pack; competency checklist; evidence of any simulation practice actually performed; unresolved reviewer/sign-off fields. |
| E10 | Reporting and continuity requirements listed; no validated route. | Incident/near-miss template; escalation/support procedure; reporting decision record; interoperability/export and supplier-exit test evidence. |
| E11 | No pilot, approval or readiness decision evidence. | Simulated pilot plan; evidence-index review; decision record with rationale, blockers and rollback criteria. Actual NHS approval remains absent. |
| E12 | Monitoring measures proposed; no dashboard, review minutes or change records. | Monitoring template plus any labelled synthetic outputs; review record; version/change log; retest/retraining triggers. |
| E13 | Baseline and follow-up not measured; feedback not collected. | Traceable synthetic evaluation dataset/results; balanced benefits review; feedback and context records; limitations and unresolved gaps. |